Synapse - Dean Bajorin

Results (275)

Actionable targets in patients with cisplatin-resistant advanced germ cell tumors

Meeting Abstract

Bagrodia, A.; Kaffenberger, S. D.; Lee, B.; Lee, W.; Cha, E. K.; Sfakianos, J.; Gao, S. P.; Zabor, E. C.; Ostrovnaya, I.; Eng, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Paclitaxel, ifosfamide, and cisplatin efficacy for first-line treatment of patients with intermediate- or poor-risk germ cell tumors

Journal Article

Feldman, D. R.; Hu, J.; Dorff, T. B.; Lim, K.; Patil, S.; Woo, K. M.; Carousso, M.; Hughes, A.; Sheinfeld, J.; Bains, M.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Barriers to a career focus in cancer prevention: A report and initial recommendations from the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group

Journal Article

Fabian, C. J.; Meyskens, F. L. Jr; Bajorin, D. F.; George, T. J. Jr; Jeter, J. M.; Khan, S.; Tyne, C. A.; William, W. N. Jr
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Association between geographic access to cancer care, insurance, and receipt of chemotherapy: Geographic distribution of oncologists and travel distance

Journal Article

Lin, C. C.; Bruinooge, S. S.; Kirkwood, M. K.; Olsen, C.; Jemal, A.; Bajorin, D.; Giordano, S. H.; Goldstein, M.; Guadagnolo, B. A.; Kosty, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Externally validated improved 5-factor prognostic model in patients (pts) receiving salvage systemic therapy for advanced urothelial carcinoma (UC)

Meeting Abstract

Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Mullane, S. A.; Niegisch, G.; Albers, P.; Necchi, A.; di Lorenzo, G.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Association between geographic access to cancer care and receipt of chemotherapy: Geographic distribution of oncologists and travel distance

Meeting Abstract

Lin, C. C.; Bruinooge, S. S.; Kirkwood, K. M.; Olsen, C. C.; Bajorin, D. F.; Jemal, A.; Giordano, S. H.; Goldstein, M.; Guadagnolo, B. A.; Kosty, M. P.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer

Meeting Abstract

Bellmunt, J.; Sonpavde, G.; De Wit, R.; Choueiri, T. K.; Siefker-Radtke, A. O.; Plimack, E. R.; Lewis, N. M.; Brown, H.; Mai, Y. B.; Gause, C. K.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma

Meeting Abstract

Bambury, R. M.; Jordan, E.; Zabor, E. C.; Bouvier, N.; Al-Ahmadie, H.; Boyd, M. E.; Mullane, S. A.; Cha, E. K.; Ostrovnaya, I.; Hyman, D. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy

Meeting Abstract

Bajorin, D. F.; Plimack, E. R.; Siefker-Radtke, A. O.; Choueiri, T. K.; De Wit, R.; Sonpavde, G.; Gipson, A.; Brown, H.; Mai, Y. B.; Pang, L.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Improved prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

Meeting Abstract

Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Mullane, S. A.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save